Author

Elvira Negrou

Denali Therapeutics (United States)ORCID 0000-0002-2475-7409Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anastasia G. HenryiD· 1 shared Annie ArguelloiD· 1 shared Ceyda Llapashtica· 1 shared Hilda O. SolanoyiD· 1 shared Hoang Ngan NguyeniD· 1 shared Laralynne PrzybylaiD· 1 shared Manuel Montalban· 1 shared Michael T. MaloneyiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anastasia G. HenryORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pRab10

Xiang Wang, Elvira Negrou, Michael T. Maloney, Vitaliy V. Bondar, Shan V. Andrews, Manuel Montalban, Ceyda Llapashtica, Romeo D. Maciuca, Hoang Ngan Nguyen, Hilda O. Solanoy, Annie Arguello, Laralynne Przybyla, Nathan J. Moerke, Sarah Huntwork, Anastasia G. Henry

The paper develops and applies quantitative assays to measure LRRK2 and pRab10 levels in cellular models and human subjects to assess LRRK2 kinase activity and its association with Parkinson's disease.

Scientific Reports · Jun 18, 2021Peer-reviewedNeuroscience